Atrish Bagchi
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
-
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
- Colorectal Cancer Treatments and Studies
Papers in
- Oncology 6
- HER2/EGFR in Cancer Research 4
- CAR-T cell therapy research 1
- Colorectal Cancer Treatments and Studies 1
- Drug Transport and Resistance Mechanisms 1
-
- RNA Research and Splicing 1
- Glycosylation and Glycoproteins Research 1
- Co-authors
- Kathryn M. Ferguson (5 shared papers)Rob C. Roovers (2 shared papers)Paul M.P. van Bergen en Henegouwen (2 shared papers)Karl R. Schmitz (2 shared papers)Mark A. Lemmon (3 shared papers)Nicholas J. Bessman (2 shared papers)Scott W. Eastman (1 shared paper)Amélie Forest (1 shared paper)
- Journals
- Structure (2 papers)Molecular Cancer Therapeutics (1 paper)Biochemical and Biophysical Research Communications (1 paper)Biophysical Journal (1 paper)Cell Reports (1 paper)
- Partner nations
- United StatesNetherlandsUnited Kingdom
In The Last Decade
Atrish Bagchi
7 papers receiving 327 citations
Peers
Comparison fields: 5 of 49
- Radiology, Nuclear Medicine and Imaging 190
- Oncology 126
- Molecular Biology 220
- Immunology 54
- Pulmonary and Respiratory Medicine 54
Countries citing papers authored by Atrish Bagchi
This map shows the geographic impact of Atrish Bagchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atrish Bagchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atrish Bagchi more than expected).
Fields of papers citing papers by Atrish Bagchi
This network shows the impact of papers produced by Atrish Bagchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atrish Bagchi. The network helps show where Atrish Bagchi may publish in the future.
Co-authors
The 25 scholars most cited alongside Atrish Bagchi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 194 | |
| 2 | 2014 | 71 | |
| 3 | 2017 | 46 | |
| 4 | 2015 | 11 | |
| 5 | 2023 | 6 | |
| 6 | 2024 | 3 | |
| 7 | 2014 | 1 |
About Atrish Bagchi
Atrish Bagchi is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Immunology and Allergy, having authored 7 papers that have together received 332 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Lung Cancer Treatments and Mutations (3 papers), CAR-T cell therapy research (1 paper), Colorectal Cancer Treatments and Studies (1 paper), RNA Research and Splicing (1 paper), Drug Transport and Resistance Mechanisms (1 paper) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (190 citations), Oncology (126 citations), Molecular Biology (220 citations), Immunology (54 citations) and Pulmonary and Respiratory Medicine (54 citations). Atrish Bagchi has collaborated with scholars based in United States, Netherlands and United Kingdom. Frequent co-authors include Kathryn M. Ferguson, Rob C. Roovers, Paul M.P. van Bergen en Henegouwen, Karl R. Schmitz, Mark A. Lemmon, Nicholas J. Bessman, Scott W. Eastman, Amélie Forest, Michal Vieth and Ruslan D. Novosiadly. Their work appears in journals such as Structure, Molecular Cancer Therapeutics, Biochemical and Biophysical Research Communications, Biophysical Journal and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.